TY - JOUR
T1 - Stoppage
T2 - An issue for segregation analysis
AU - Slager, S. L.
AU - Foroud, T.
AU - Haghighi, F.
AU - Spence, M. A.
AU - Hodge, S. E.
N1 - Funding Information:
Research funding: This work is supported by King Abdulaziz City for Science and Technology, Riyad, Saudi Arabia, grant numbers 12-MED2797-46 and14-MED1918-46. This is a government agency. They have no role in the design, collection, analysis and interpretation of the data and writing of the manuscript.
Funding Information:
The authors would like to acknowledge the financial supported extended by King Abdulaziz City for Science and Technology, Riyad, Saudi Arabia, grant numbers 12-MED2797-46 and 14-MED1918-46. Folkert Asselbergs is supported by UCL Hospitals NIHR Biomedical Research Centre. We are also grateful to the nurses and technical staff for their work and dedication.
PY - 2001
Y1 - 2001
N2 - Segregation analysis assumes that the observed family-size distribution (FSD), i.e., distribution of number of offspring among nuclear families, is independent of the segregation ratio p. However, for certain serious diseases with early onset and diagnosis (e.g., autism), parents may change their original desired family size, based on having one or more affected children, thus violating that assumption. Here we investigate "stoppage," the situation in which such parents have fewer children than originally planned. Following Brookfield et al. [J Med Genet 25:181-185, 1988], we define a stoppage probability d that after the birth of an affected child, parents will stop having children and thus not reach their original desired family size. We first derive the full correct likelihood for a simple segregation analysis as a function of p, d, and the ascertainment probability π. We show that p can be estimated from this likelihood if the FSD is known. Then, we show that under "random" ascertainment, the presence of stoppage does not bias estimates of p. However, for other ascertainment schemes, we show that is not the case. We use a simulation study to assess the magnitude of bias, and we demonstrate that ignoring the effect of stoppage can seriously bias the estimates of p when the FSD is ignored. In conclusion, stoppage, a realistic scenario for some complex diseases, can represent a serious and potentially intractable problem for segregation analysis.
AB - Segregation analysis assumes that the observed family-size distribution (FSD), i.e., distribution of number of offspring among nuclear families, is independent of the segregation ratio p. However, for certain serious diseases with early onset and diagnosis (e.g., autism), parents may change their original desired family size, based on having one or more affected children, thus violating that assumption. Here we investigate "stoppage," the situation in which such parents have fewer children than originally planned. Following Brookfield et al. [J Med Genet 25:181-185, 1988], we define a stoppage probability d that after the birth of an affected child, parents will stop having children and thus not reach their original desired family size. We first derive the full correct likelihood for a simple segregation analysis as a function of p, d, and the ascertainment probability π. We show that p can be estimated from this likelihood if the FSD is known. Then, we show that under "random" ascertainment, the presence of stoppage does not bias estimates of p. However, for other ascertainment schemes, we show that is not the case. We use a simulation study to assess the magnitude of bias, and we demonstrate that ignoring the effect of stoppage can seriously bias the estimates of p when the FSD is ignored. In conclusion, stoppage, a realistic scenario for some complex diseases, can represent a serious and potentially intractable problem for segregation analysis.
KW - Ascertainment models
KW - Complex disease
KW - Segregation ratio
KW - Sequential sampling
UR - https://www.scopus.com/pages/publications/0035076652
U2 - 10.1002/gepi.4
DO - 10.1002/gepi.4
M3 - Article
C2 - 11255242
AN - SCOPUS:0035076652
SN - 0741-0395
VL - 20
SP - 328
EP - 339
JO - Genetic Epidemiology
JF - Genetic Epidemiology
IS - 3
ER -